National Newswatch

PMPRB Self-Monitoring of Outcomes of New Rules Will Fail Patients

Jun 3 2021 — Nigel Rawson and Olaf Koester — On July 1, 2021, new regulations for the Patented Medicine Prices Review Board (PMPRB), a little-known federal tribunal that ensures prices of patented medicines in Canada are not excessive, will be implemented, unless delayed or halted by court challenges or the federal Cabinet. The regulatory amendments will allow the PMPRB to remove the United States and Switzerland (both high […]